Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InterCannAlliance (ICA) is a global consultancy and management firm specializing in the medical cannabis industry. The company provides end-to-end solutions for the establishment of medical-grade cannabis operations, including regulatory compliance, facility design, and cultivation management. ICA focuses on implementing pharmaceutical-grade standards such as EU-GMP to ensure the production of high-quality cannabinoid-based products. By bridging the gap between agricultural expertise and pharmaceutical requirements, the firm assists international partners in navigating the complex legal and technical landscape of the global cannabis market. Their services extend to market entry strategies, product branding, and distribution network development. The company operates with a 'Seed-to-Pharma' philosophy, emphasizing quality control at every stage of the supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InterCannAlliance.